Bipolar Disorder: Assessment for diabetes

Patients 18 years of age or older with an initial or new episode of bipolar disorder
AND
Documentation of a diagnosis of bipolar disorder; to include at least one of the following:
• Codes 296.0x; 296.1x; 296.4x; 296.5x; 296.6x; 296.7; 296.80; 296.81; 296.82; 296.89; 301.13 documented in body of chart, such as a pre-printed form completed by a clinician and/or codes documented in chart notes/forms
OR
• Diagnosis or Impression or “working diagnosis” documented in chart indicating bipolar disorder
OR
• Use of a screening/assessment tool for bipolar disorder with a score or conclusion that patient has bipolar disorder and documentation that this information is used to establish or substantiate the diagnosis
AND
Documentation of treatment with an atypical antipsychotic agent. (See reference list below)
Note: It is not the intent to indicate preferred pharmacotherapy. The reference list is inclusive of those atypical antipsychotic medications that are reasonably construed to be appropriate in accordance with current guidelines. (Reference list of medications also included in data collection form)
Atypical Antipsychotic Agents
• aripiprazole
• quetiapine
• clozapine
• risperidone
• olanzapine
• ziprasidone
• olanzapine-fluoxetine (combination)

None. New diagnosis” or a “new episode,” is defined as cases where the patient has not been involved in active treatment for 6 months. Active treatment includes being hospitalized or under the out-patient care of a physician.